Toxicology Drug Testing Market Revenue to Cross USD 55.9 billion by 2031, Growing at a CAGR of 5.5% Says Transparency Market Research
Transparency Market Research
Transparency Market Research

Increasing demand for toxicology drug testing in various fields, including healthcare, workplace safety, forensic investigations, sports, addiction treatment, and pharmaceutical research, boost the market demand.

Wilmington, Delaware, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global toxicology drug testing market is projected to flourish at a CAGR of 5.5% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 55.9 billion is anticipated for the market in 2031. As of 2023, the market for toxicology drug testing is expected to close at US$ 36.5 billion.

Technological advancements in toxicology drug testing, increasing R&D activities in pharmaceutical companies, and rise in demand for toxicology drug testing in pharmaceuticals and biotechnology companies across the globe are key factors driving the toxicology drug testing industry.

Request for Sample PDF Brochure at: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85789

Competitive Landscape

The global toxicology drug testing market is fragmented, with the presence of a small number of leading players. The leading players in the market are investing in new product development, mergers, and acquisitions to gain a competitive edge. Transparency Market Research has profiled the following players in its global toxicology drug testing market report:

  • TDAL Labs

  • Thermo Fisher Scientific Inc.

  • Abbott

  • Clinisys, Inc.

  • Laboratory Corporation of America Holdings

  • SLUCARE

  • Icahn School of Medicine at Mount Sinai

  • Keystone Lab

  • Shimadzu Scientific Instruments

  • Ganesh Diagnostic & Imaging Centre Pvt. Ltd.

  • Other Player

Key Developments in the Toxicology Drug Testing Market

  • TDAL Labs – offer on-site testing and mobile testing throughout New Orleans and much of South Louisiana in addition to lab-based drug or alcohol testing collections at our locally-owned downtown facilities.

  • Thermo Fisher Scientific developed advanced analytical instruments and technologies for drug testing, offering high sensitivity and accuracy in detecting various drug compounds.The company collaborated with research institutions to develop novel testing methods, including the analysis of designer drugs and emerging substances.

  • Quest Diagnostics introduced innovative testing solutions, such as oral fluid drug testing, which provides an alternative to urine-based testing and offers faster results. The company emphasized its efforts to enhance the use of data analytics to improve the interpretation of drug test results.